Year archive

CLINUVEL PHARMACEUTICALS LIMITED — 2025 filings

All 67 regulatory filings released by CLINUVEL PHARMACEUTICALS LIMITED (CUV) in 2025, sourced directly from the official regulator.

67 Filings

2025 Period

2025 filings (67)

Filing	Released	Lang
CLINUVEL progresses Level II ADR upgrade, Nasdaq uplist 3 pages 113.9KB Regulatory Filings	2025-12-18	English
CLINUVEL expands Singapore RD&I Centre 3 pages 141.5KB Regulatory Filings	2025-12-07	English
CLINUVEL advances NEURACTHEL Instant, EU filing mid-2026 3 pages 106.9KB Capital/Financing Update	2025-12-01	English
Stifel Healthcare Conference presentation 16 pages 5.9MB Investor Presentation	2025-11-13	English
Change in substantial holding 8 pages 383.6KB Major Shareholding Notification	2025-11-11	English
Update on ADR upgrade, Nasdaq uplisting 2 pages 75.2KB Regulatory Filings	2025-11-02	English
Chair address 5 pages 251.7KB AGM Information	2025-10-16	English
Managing Director Address 8 pages 396.7KB AGM Information	2025-10-16	English
Results of Meeting 3 pages 115.3KB Declaration of Voting Results & Voting Rights Announcements	2025-10-16	English
Health Canada requests additional time for SCENESSE review 2 pages 113.0KB Regulatory Filings	2025-10-15	English
Application for quotation of securities - CUV 6 pages 18.4KB Share Issue/Capital Change	2025-10-02	English
Application for quotation of securities - CUV 6 pages 19.1KB Share Issue/Capital Change	2025-10-02	English
Notification of cessation of securities - CUV 4 pages 15.2KB Share Issue/Capital Change	2025-10-02	English
Section 708A Cleansing Statement 2 pages 75.5KB Capital/Financing Update	2025-10-02	English
Management update 2 pages 72.7KB Board/Management Information	2025-09-30	English
CLINUVEL advances new formulations in preclinical program 2 pages 116.3KB Regulatory Filings	2025-09-28	English
EMA approves year-round SCENESSE treatment 3 pages 115.1KB Regulatory Filings	2025-09-22	English
SCENESSE efficacy in vitiligo - new cases presented to EADV 5 pages 546.2KB Regulatory Filings	2025-09-18	English
Becoming a substantial holder 25 pages 1.9MB Major Shareholding Notification	2025-09-16	English
Notice of Annual General Meeting/Proxy Form 15 pages 426.4KB AGM Information	2025-09-14	English
Chair's Letter to Shareholders 4 pages 160.4KB Annual Report FY 2025	2025-09-04	English
Date of Annual General Meeting 2 pages 73.4KB AGM Information	2025-09-02	English
CLINUVEL Annual Results - Investor Webinar 2 pages 71.9KB Report Publication Announcement	2025-08-28	English
Appendix 4E and Annual Report to Shareholders 2025 159 pages 19.2MB Regulatory Filings	2025-08-27	English
CLINUVEL delivers ninth consecutive revenues growth & profit 4 pages 157.5KB Annual Report FY 2025	2025-08-27	English
Dividend/Distribution - CUV 4 pages 15.5KB Notice of Dividend Amount	2025-08-27	English
Appendix 4G 13 pages 410.0KB Governance Information	2025-08-27	English
Corporate Governance Statement 11 pages 320.4KB Governance Information	2025-08-27	English
Investor Presentation 11 pages 1.7MB Management Reports	2025-08-27	English
CLINUVEL preparing upgrade of ADR program, NASDAQ uplist 3 pages 105.1KB Capital/Financing Update	2025-08-21	English
CLINUVEL Annual Results - Investor Webinar 2 pages 73.5KB Investor Presentation	2025-08-20	English
Bioshares Biotech Summit presentation 23 pages 2.0MB Investor Presentation	2025-08-06	English
Presentation to BTIG Biotech Conference 19 pages 1.5MB Investor Presentation	2025-07-29	English
Notification of cessation of securities - CUV 4 pages 14.7KB Share Issue/Capital Change	2025-07-01	English
German Non-deal Roadshow Presentation 14 pages 1.9MB Regulatory Filings	2025-06-23	English
Ceasing to be a substantial holder 19 pages 1.1MB Major Shareholding Notification	2025-06-18	English
Becoming a substantial holder 25 pages 1.6MB Major Shareholding Notification	2025-06-17	English
Study confirms NB-UVB needed to activate repigmentation 3 pages 97.1KB Regulatory Filings	2025-06-17	English
SCENESSE successfully administered to paediatric EPP patient 2 pages 74.5KB Regulatory Filings	2025-06-12	English
CLINUVEL management update 2 pages 67.8KB Board/Management Information	2025-06-12	English
SCENESSE in Vitiligo - A Global Update 6 pages 19.5MB Investor Presentation	2025-06-03	English
SCENESSE EPP data featured at EADV Symposium 2 pages 85.2KB Regulatory Filings	2025-05-21	English
Ceasing to be a substantial holder 23 pages 1.4MB Major Shareholding Notification	2025-05-08	English
CUV recruits 200 patients in Phase III vitiligo trial CUV105 4 pages 285.8KB Regulatory Filings	2025-05-06	English
Notification regarding unquoted securities - CUV 6 pages 19.7KB Share Issue/Capital Change	2025-04-22	English
Notification of cessation of securities - CUV 4 pages 14.7KB Share Issue/Capital Change	2025-04-08	English
Application for quotation of securities - CUV 6 pages 18.3KB Share Issue/Capital Change	2025-04-06	English
Application for quotation of securities - CUV 6 pages 19.2KB Share Issue/Capital Change	2025-04-06	English
Section 708A Cleansing Statement 2 pages 83.8KB Regulatory Filings	2025-04-06	English
Change in substantial holding 24 pages 1.7MB Major Shareholding Notification	2025-03-31	English
Update - Notification of buy-back - CUV 6 pages 18.0KB Transaction in Own Shares	2025-03-26	English
CLINUVEL renews share buy-back program 2 pages 79.3KB Transaction in Own Shares	2025-03-26	English
Notification of buy-back - CUV 5 pages 15.4KB Transaction in Own Shares	2025-03-26	English
Positive preliminary results for PRENUMBRA Instant in stroke 3 pages 106.1KB Regulatory Filings	2025-03-25	English
2025 American Academy of Dermatology Annual Meeting 13 pages 5.9MB AGM Information	2025-03-23	English
CLINUVEL management update 3 pages 81.2KB Board/Management Information	2025-03-17	English
CLINUVEL Unveils Vitiligo Program for AAD 2025 3 pages 117.6KB Regulatory Filings	2025-03-03	English
Chair Letter to Shareholders 3 pages 93.8KB Interim / Quarterly Report H1 2025	2025-02-27	English
CLINUVEL Investor Webinar 2 pages 67.6KB Report Publication Announcement	2025-02-27	English
Appendix 4D and Half Year Report 22 pages 1.1MB Interim / Quarterly Report H1 2025	2025-02-26	English
Half Year Results Announcement 4 pages 146.1KB Interim / Quarterly Report H1 2025	2025-02-26	English
Half Year Results Presentation 19 pages 939.5KB Regulatory Filings	2025-02-26	English
CLINUVEL Investor Webinar 2 pages 117.5KB Regulatory Filings	2025-02-19	English
Change in substantial holding 26 pages 1.5MB Major Shareholding Notification	2025-02-16	English
Preliminary results from SCENESSE adolescent EPP study 3 pages 127.1KB Regulatory Filings	2025-02-09	English
Vitiligo - CUV105 Study Update 15 pages 2.8MB Regulatory Filings	2025-01-19	English
SCENESSE Argentinian distribution agreement 2 pages 76.8KB Regulatory Filings	2025-01-16	English

Filings by year

2026 21 filings
2025 67 filings
2024 96 filings
2023 62 filings
2022 63 filings
2021 59 filings
2020 69 filings
2019 72 filings
2018 54 filings
2017 32 filings
2016 52 filings
2015 36 filings
2014 59 filings
2013 39 filings
2012 38 filings
2011 47 filings
2010 56 filings
2009 45 filings
2008 43 filings
2007 54 filings
2006 10 filings
2005 74 filings
2004 49 filings
2003 53 filings
2002 2 filings